Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis (ATTR-CA): New Horizons in Disease Staging and Follow-Up

NCT07766135 is registered in ClinicalTrials.gov with University of Messina as lead sponsor.

NCT NCT07766135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07766135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis (ATTR-CA): New Horizons in Disease Staging and Follow-Up
Lead sponsor
University of Messina
Phase
Observational
Overall status
Recruiting
Start date
January 30, 2026
Completion date
January 31, 2028
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis, cardiomyopathies, hereditary transthyretin amyloidosis (attrv), transthyretin (ttr) amyloid cardiomyopathy, wild-type transthyretin cardiac amyloidosis